Vimarsana
Biggest News Aggregation in the World

Page 3 - Biotools Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotools Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotools Inc Today - Breaking & Trending Today

Short Interest in Standard BioTools Inc. (NASDAQ:LAB) Increases By 28.5% - Vimarsana News

Short Interest in Standard BioTools Inc. (NASDAQ:LAB) Increases By 28.5%

Standard BioTools Inc. (NASDAQ:LAB – Get Free Report) was the target of a large growth in short interest in September. As of September 30th, there was short interest totalling 3,520,000 shares, a growth of 28.5% from the September 15th total of 2,740,000 shares. Approximately 4.6% of the shares of the stock are short sold. Based […]

Contrasting Quanterix (NASDAQ:QTRX) & Standard BioTools (NASDAQ:LAB) - Vimarsana News

Contrasting Quanterix (NASDAQ:QTRX) & Standard BioTools (NASDAQ:LAB)

Quanterix (NASDAQ:QTRX – Get Free Report) and Standard BioTools (NASDAQ:LAB – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability. Institutional & Insider Ownership 86.6% of Quanterix shares […]

Rapid Micro Biosystems (NASDAQ:RPID) & Standard BioTools (NASDAQ:LAB) Head to Head Analysis - Vimarsana News

Rapid Micro Biosystems (NASDAQ:RPID) & Standard BioTools (NASDAQ:LAB) Head to Head Analysis

Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) and Standard BioTools (NASDAQ:LAB – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability. Institutional & Insider Ownership 51.7% of […]

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2023 - Itron (NASDAQ:ITRI), Lazard (NYSE:LAZ), Model N (NYSE:MODN), STMicroelectronics (NYSE:STM), Coinbase Glb (NASDAQ:COIN), Elevance Health (NYSE:ELV), DoubleVerify Hldgs (NYSE:DV), Ncino (NASDAQ:NCNO), Chart Industries (NYSE:GTLS), High Tide (NASDAQ:HITI), ReNew Energy Glb (NASDAQ:RNW), DraftKings (NASDAQ:DKNG), TJX Companies (NYSE:TJX), Kinder Morgan (NYSE:KMI), Morgan Stanley (NYSE:MS), Sun Communities (NYSE:SUI), Imperial Oil (AMEX:IMO), Holley (NYSE:HLLY), Jack Henry & Associates (NASDAQ:JKHY), Stellantis (NYSE:STLA), UMH Properties (NYSE:UMH), Sealed Air (NYSE:SEE), Cenovus Energy (NYSE:CVE), Activision Blizzard (NASDAQ:ATVI), Centene (NYSE:CNC), Cinemark Hldgs (NYSE:CNK), Cisco Systems (NASDAQ:CSCO), Western Midstream (NYSE:WES), Saratoga Investment (NYSE:SAR), JPMorgan Chase (NYSE:JPM), Canadian Natural Res (NYSE:CNQ), RXO (NYSE:RXO), Seritage Growth Props (NYSE:SRG), Alkami Technology (NASDAQ:ALKT), Marathon Oil (NYSE:MRO), CACI International (NYSE:CACI), Redfin (NASDAQ:RDFN), SunPower (NASDAQ:SPWR), Alpha Teknova (NASDAQ:TKNO), Quad/Graphics (NYSE:QUAD), Suncor Energy (NYSE:SU), W.W. Grainger (NYSE:GWW), Jefferies Financial Gr (NYSE:JEF), Standard BioTools (NASDAQ:LAB), Lennox Intl (NYSE:LII), BlackSky Technology (NYSE:BKSY), Beazer Homes USA (NYSE:BZH), Fidelity National Info (NYSE:FIS), APA (NASDAQ:APA), Silk Road Medical (NASDAQ:SILK), Integra Lifesciences (NASDAQ:IART), Atlassian (NASDAQ:TEAM), AlTi Global (NASDAQ:ALTI) - Vimarsana News

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2023 - Itron (NASDAQ:ITRI), Lazard (NYSE:LAZ), Model N (NYSE:MODN), STMicroelectronics (NYSE:STM), Coinbase Glb (NASDAQ:COIN), Elevance Health (NYSE:ELV), DoubleVerify Hldgs (NYSE:DV), Ncino (NASDAQ:NCNO), Chart Industries (NYSE:GTLS), High Tide (NASDAQ:HITI), ReNew Energy Glb (NASDAQ:RNW), DraftKings (NASDAQ:DKNG), TJX Companies (NYSE:TJX), Kinder Morgan (NYSE:KMI), Morgan Stanley (NYSE:MS), Sun Communities (NYSE:SUI), Imperial Oil (AMEX:IMO), Holley (NYSE:HLLY), Jack Henry & Associates (NASDAQ:JKHY), Stellantis (NYSE:STLA), UMH Properties (NYSE:UMH), Sealed Air (NYSE:SEE), Cenovus Energy (NYSE:CVE), Activision Blizzard (NASDAQ:ATVI), Centene (NYSE:CNC), Cinemark Hldgs (NYSE:CNK), Cisco Systems (NASDAQ:CSCO), Western Midstream (NYSE:WES), Saratoga Investment (NYSE:SAR), JPMorgan Chase (NYSE:JPM), Canadian Natural Res (NYSE:CNQ), RXO (NYSE:RXO), Seritage Growth Props (NYSE:SRG), Alkami Technology (NASDAQ:ALKT), Marathon Oil (NYSE:MRO), CACI International (NYSE:CACI), Redfin (NASDAQ:RDFN), SunPower (NASDAQ:SPWR), Alpha Teknova (NASDAQ:TKNO), Quad/Graphics (NYSE:QUAD), Suncor Energy (NYSE:SU), W.W. Grainger (NYSE:GWW), Jefferies Financial Gr (NYSE:JEF), Standard BioTools (NASDAQ:LAB), Lennox Intl (NYSE:LII), BlackSky Technology (NYSE:BKSY), Beazer Homes USA (NYSE:BZH), Fidelity National Info (NYSE:FIS), APA (NASDAQ:APA), Silk Road Medical (NASDAQ:SILK), Integra Lifesciences (NASDAQ:IART), Atlassian (NASDAQ:TEAM), AlTi Global (NASDAQ:ALTI)

Standard BioTools Get a Buy Rating, Analyst Cites Unique Technology, Management and Board - Standard BioTools (NASDAQ:LAB) - Vimarsana News

Standard BioTools Get a Buy Rating, Analyst Cites Unique Technology, Management and Board - Standard BioTools (NASDAQ:LAB)

KeyBanc Capital Markets initiated coverage on Standard BioTools Inc (NASDAQ: LAB) with an Overweight rating and a